Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan: A nationwide longitudinal study

S. Y. Li, T. J. Chen, K. W. Chung, L. W. Tsai, W. C. Yang, J. Y. Chen, T. W. Chen

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

End-stage renal disease (ESRD) patients are vulnerable to Mycobacterium tuberculosis (MTB) infection, but the magnitude of the risk is uncertain. In addition, there is no reliable information on the MTB infection rate of patients undergoing different types of renal replacement therapy (RRT). We used the Taiwan National Health Insurance Research Database to conduct a 9-year nationwide longitudinal study. Among 49983 ESRD patients who received three renal replacement modalities, there were 562 cases of MTB infection, corresponding to an incidence rate of 3.0 per 1000 patient-years. The risk of MTB infection relative to the general population was 4.5. Multivariate Cox regression analysis indicated that the independent risk factors for MTB infection in ESRD patients are old age (hazard ratio (HR) 1.17 per 10 years, p

Original languageEnglish
Pages (from-to)1646-1652
Number of pages7
JournalClinical Microbiology and Infection
Volume17
Issue number11
DOIs
Publication statusPublished - Nov 2011

Fingerprint

Mycobacterium Infections
Taiwan
Mycobacterium tuberculosis
Chronic Kidney Failure
Longitudinal Studies
Renal Replacement Therapy
National Health Programs
Regression Analysis
Databases
Kidney
Incidence
Research
Population

Keywords

  • End-stage renal disease
  • Mycobacterium tuberculosis
  • Renal replacement therapy
  • Taiwan National Health Insurance Research Database

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan : A nationwide longitudinal study. / Li, S. Y.; Chen, T. J.; Chung, K. W.; Tsai, L. W.; Yang, W. C.; Chen, J. Y.; Chen, T. W.

In: Clinical Microbiology and Infection, Vol. 17, No. 11, 11.2011, p. 1646-1652.

Research output: Contribution to journalArticle

Li, S. Y. ; Chen, T. J. ; Chung, K. W. ; Tsai, L. W. ; Yang, W. C. ; Chen, J. Y. ; Chen, T. W. / Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan : A nationwide longitudinal study. In: Clinical Microbiology and Infection. 2011 ; Vol. 17, No. 11. pp. 1646-1652.
@article{bbb9e9e692ad454cb255ca4fdd813fc4,
title = "Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan: A nationwide longitudinal study",
abstract = "End-stage renal disease (ESRD) patients are vulnerable to Mycobacterium tuberculosis (MTB) infection, but the magnitude of the risk is uncertain. In addition, there is no reliable information on the MTB infection rate of patients undergoing different types of renal replacement therapy (RRT). We used the Taiwan National Health Insurance Research Database to conduct a 9-year nationwide longitudinal study. Among 49983 ESRD patients who received three renal replacement modalities, there were 562 cases of MTB infection, corresponding to an incidence rate of 3.0 per 1000 patient-years. The risk of MTB infection relative to the general population was 4.5. Multivariate Cox regression analysis indicated that the independent risk factors for MTB infection in ESRD patients are old age (hazard ratio (HR) 1.17 per 10 years, p",
keywords = "End-stage renal disease, Mycobacterium tuberculosis, Renal replacement therapy, Taiwan National Health Insurance Research Database",
author = "Li, {S. Y.} and Chen, {T. J.} and Chung, {K. W.} and Tsai, {L. W.} and Yang, {W. C.} and Chen, {J. Y.} and Chen, {T. W.}",
year = "2011",
month = "11",
doi = "10.1111/j.1469-0691.2011.03473.x",
language = "English",
volume = "17",
pages = "1646--1652",
journal = "Clinical Microbiology and Infection",
issn = "1198-743X",
publisher = "Elsevier Limited",
number = "11",

}

TY - JOUR

T1 - Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan

T2 - A nationwide longitudinal study

AU - Li, S. Y.

AU - Chen, T. J.

AU - Chung, K. W.

AU - Tsai, L. W.

AU - Yang, W. C.

AU - Chen, J. Y.

AU - Chen, T. W.

PY - 2011/11

Y1 - 2011/11

N2 - End-stage renal disease (ESRD) patients are vulnerable to Mycobacterium tuberculosis (MTB) infection, but the magnitude of the risk is uncertain. In addition, there is no reliable information on the MTB infection rate of patients undergoing different types of renal replacement therapy (RRT). We used the Taiwan National Health Insurance Research Database to conduct a 9-year nationwide longitudinal study. Among 49983 ESRD patients who received three renal replacement modalities, there were 562 cases of MTB infection, corresponding to an incidence rate of 3.0 per 1000 patient-years. The risk of MTB infection relative to the general population was 4.5. Multivariate Cox regression analysis indicated that the independent risk factors for MTB infection in ESRD patients are old age (hazard ratio (HR) 1.17 per 10 years, p

AB - End-stage renal disease (ESRD) patients are vulnerable to Mycobacterium tuberculosis (MTB) infection, but the magnitude of the risk is uncertain. In addition, there is no reliable information on the MTB infection rate of patients undergoing different types of renal replacement therapy (RRT). We used the Taiwan National Health Insurance Research Database to conduct a 9-year nationwide longitudinal study. Among 49983 ESRD patients who received three renal replacement modalities, there were 562 cases of MTB infection, corresponding to an incidence rate of 3.0 per 1000 patient-years. The risk of MTB infection relative to the general population was 4.5. Multivariate Cox regression analysis indicated that the independent risk factors for MTB infection in ESRD patients are old age (hazard ratio (HR) 1.17 per 10 years, p

KW - End-stage renal disease

KW - Mycobacterium tuberculosis

KW - Renal replacement therapy

KW - Taiwan National Health Insurance Research Database

UR - http://www.scopus.com/inward/record.url?scp=80054083433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054083433&partnerID=8YFLogxK

U2 - 10.1111/j.1469-0691.2011.03473.x

DO - 10.1111/j.1469-0691.2011.03473.x

M3 - Article

C2 - 21375664

AN - SCOPUS:80054083433

VL - 17

SP - 1646

EP - 1652

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - 11

ER -